MTX-induced pneumonitis is a rare complication of RA treatment and much remains unknown about it. Chikura, et al present the first study to describe the variation of immunological response in MTX-P. Rheumatology
Review recent data supporting safety and efficacy of B-cell-depleting agents for RA, as illustrated by data presented at American College of Rheumatology 2007 Annual Meeting. Medscape Rheumatology
Identifying biomarkers of response and toxicity can help clinicians select the most safe and effective drugs for individual patients with rheumatoid arthritis. Personalized Medicine
The results of this study support the benefits of exercise and manual therapy in the clinical management of patients with osteoporotic vertebral fractures. BMC Musculoskeletal Disorders
This finding adds to the growing body of evidence supporting the value of initiating statin therapy in rheumatoid arthritis patients, especially those with evidence of coronary heart disease. Medscape Medical News